DOWNLOAD

The global market access checklist

Key considerations for pharmaceutical and medical device companies entering new markets

Life sciences companies seeking global market access expansion must understand the vital factors that pertain to securing payer and provider coverage in foreign markets as well as the crucial evidence generation strategies needed for product acceptance.

Download our checklist to help your organization gain optimal global market access for your medical device or technologies. This checklist can be used to aid in the planning of key market access initiatives including:

  • Clinical and economic evidence strategy and generation
  • Market intelligence, sizing and new indication strategy
  • Stakeholders and advocacy
  • Early access programs (EAPs)
  • Key stakeholder outreach and Health Technology Assessment submission
  • Legal considerations
  • Value-based reimbursement strategy

This checklist specifically addresses the key considerations for life sciences companies entering the EU5 countries of France, Germany, Italy, Spain and the U.K. Given the distinct strategies and priorities of pharmaceutical companies and medical device manufacturers, this checklist is divided into two sections tailored to meet the specific requirements of each life sciences segment.

Have a question for one of our specialists? Contact us


Download the checklist

Provide your information to download the global market access checklist.

Baker Tilly US, LLP and Baker Tilly Advisory Group, LP and its subsidiary entities provide professional services through an alternative practice structure in accordance with the AICPA Code of Professional Conduct and applicable laws, regulations and professional standards. Baker Tilly US, LLP is a licensed independent CPA firm that provides attest services to clients. Baker Tilly Advisory Group, LP and its subsidiary entities provide tax and business advisory services to their clients. Baker Tilly Advisory Group, LP and its subsidiary entities are not licensed CPA firms. © Baker Tilly Advisory Group, LP

Baker Tilly Advisory Group, LP and Baker Tilly US, LLP are independent members of Baker Tilly International. Baker Tilly International Limited is an English company. Baker Tilly International provides no professional services to clients. Each member firm is a separate and independent legal entity and each describes itself as such. Baker Tilly Advisory Group, LP and Baker Tilly US, LLP are not Baker Tilly International’s agent and do not have the authority to bind Baker Tilly International or act on Baker Tilly International’s behalf. None of Baker Tilly International, Baker Tilly Advisory Group, LP, Baker Tilly US, LLP, nor any of the other member firms of Baker Tilly International has any liability for each other’s acts or omissions. The name Baker Tilly and its associated logo is used under license from Baker Tilly International Limited.